Zenas BioPharma, Inc.
ZBIO
$7.58
-$0.22-2.82%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 350.77M | 386.80M | 183.93M | 37.15M | 56.86M |
| Total Receivables | -- | -- | -- | 1.00M | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 3.07M | 6.98M | 3.47M | 1.55M | 1.65M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 2.09M | -- | 1.20M | -- | 1.30M |
| Total Current Assets | 355.92M | 393.78M | 188.60M | 39.71M | 59.80M |
|
|
|||||
| Total Current Assets | 355.92M | 393.78M | 188.60M | 39.71M | 59.80M |
| Net Property, Plant & Equipment | 1.19M | 545.00K | 706.00K | 847.00K | 1.01M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 12.86M | 9.11M | 10.65M | 8.50M | 7.36M |
| Total Assets | 369.97M | 403.43M | 199.95M | 49.05M | 68.18M |
|
|
|||||
| Total Accounts Payable | 17.14M | 15.08M | 8.36M | 8.63M | 5.40M |
| Total Accrued Expenses | 39.16M | 28.53M | 29.73M | 19.39M | 17.01M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 785.00K | 384.00K | 494.00K | 516.00K | 556.00K |
| Total Finance Division Other Current Liabilities | 211.00K | -- | 530.00K | 1.80M | 301.00K |
| Total Other Current Liabilities | 211.00K | -- | 530.00K | 1.80M | 301.00K |
| Total Current Liabilities | 57.29M | 44.00M | 39.11M | 30.33M | 23.26M |
|
|
|||||
| Total Current Liabilities | 57.29M | 44.00M | 39.11M | 30.33M | 23.26M |
| Long-Term Debt | -- | -- | -- | 20.99M | 20.30M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 218.00K | -- | 14.00K | 133.00K | 257.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 57.51M | 44.00M | 39.12M | 51.46M | 43.82M |
|
|
|||||
| Common Stock & APIC | 699.66M | 694.17M | 7.29M | 5.63M | 4.65M |
| Retained Earnings | -387.39M | -334.79M | -296.18M | -258.20M | -230.40M |
| Treasury Stock & Other | 194.00K | 54.00K | 104.00K | 74.00K | 37.00K |
| Total Common Equity | 312.46M | 359.44M | -288.78M | -252.50M | -225.72M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | 449.61M | 250.09M | 250.09M |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | 449.61M | 250.09M | 250.09M |
|
|
|||||
| Total Common Equity | 312.46M | 359.44M | -288.78M | -252.50M | -225.72M |
| Total Preferred Equity | -- | -- | 449.61M | 250.09M | 250.09M |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 312.46M | 359.44M | 160.83M | -2.41M | 24.37M |
|
|
|||||
